Literature DB >> 14713773

The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract.

Sungchan Park1, Bumsik Hong, Choung-Soo Kim, Hanjong Ahn.   

Abstract

PURPOSE: We assessed the impact of traditional prognostic factors and tumor location on the survival of patients treated for upper tract transitional cell carcinoma (TCC).
MATERIALS AND METHODS: We retrospectively analyzed the data on 86 patients with upper tract TCC who underwent nephroureterectomy with a bladder cuff (95%) or parenchymal sparing surgery (5%). Mean patient age was 59.5 years and median followup was 43.8 months. The influence of traditional prognostic factors such as age, gender, tumor stage, grade and location on 5-year disease specific and recurrence-free (local recurrence or distant metastasis) survival rates was analyzed. The difference in survival rates between renal 45 pelvis and 41 ureteral cases was analyzed according to the respective T stage and grade.
RESULTS: Overall 5-year disease specific and recurrence-free survival rates were 83% and 72%, respectively. The significant prognostic factors for survival rates by univariate analysis were T stage, grade and location. N stage was significant for 5-year recurrence-free survival. On multivariate analysis tumor location was the only independent prognostic factor for the 2 survival rates, while N stage was significant for 5-year recurrence-free survival. Patients with ureteral tumor had a worse prognosis than those with pelvis tumor at the same stage or grade (p = 0.036).
CONCLUSIONS: Pelvis and ureteral TCC are not the same disease in terms of invasion and prognosis. Ureteral TCC is associated with a higher local or distant failure rate than renal pelvis TCC. A radical surgical approach including meticulous lymphadenectomy may be therapeutic in patients with invasive ureteral TCC.

Entities:  

Mesh:

Year:  2004        PMID: 14713773     DOI: 10.1097/01.ju.0000107767.56680.f7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  38 in total

1.  [Urothelial carcinoma of the upper urinary tract: clinical and pathological criteria and their predictive implications after radical nephroureterectomy].

Authors:  Christian Seitz; Paul Schramek
Journal:  Wien Med Wochenschr       Date:  2011-08

2.  Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients.

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Diaa Eldin Taha; Samer El-Halwagy
Journal:  Turk J Urol       Date:  2018-03-06

3.  Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?

Authors:  Hanan Goldberg; Douglas C Cheung; Thenappan Chandrasekar; Zachary Klaassen; Christopher J D Wallis; Girish S Kulkarni; Rashid Sayyid; Andrew Evans; Mehdi Masoomian; Bharati Bapat; Theodorus van der Kwast; Robert J Hamilton; Alexandre Zlotta; Neil Fleshner
Journal:  Can Urol Assoc J       Date:  2019-01-21       Impact factor: 1.862

4.  The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study.

Authors:  Atsunari Kawashima; Yasutomo Nakai; Masashi Nakayama; Takeshi Ujike; Go Tanigawa; Yutaka Ono; Akihito Kamoto; Tsuyosi Takada; Yuichiro Yamaguchi; Hitoshi Takayama; Kazuo Nishimura; Norio Nonomura; Akira Tsujimura
Journal:  World J Urol       Date:  2011-10-09       Impact factor: 4.226

5.  Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

Authors:  Eiji Kikuchi; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Shuji Mikami; Yair Lotan; Mesut Remzi; Christian Bolenz; Cord Langner; Alon Weizer; Francesco Montorsi; Karim Bensalah; Theresa M Koppie; Mario I Fernández; Jay D Raman; Wassim Kassouf; Christopher G Wood; Nazareno Suardi; Mototsugu Oya; Shahrokh F Shariat
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

6.  Synchronous ipsilateral renal cell carcinoma and urothelial carcinoma of the renal pelvis.

Authors:  Mike Leveridge; Phillip A Isotalo; Alexander H Boag; Jun Kawakami
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

7.  Preoperative hydronephrosis and diabetes mellitus predict poor prognosis in upper urinary tract urothelial carcinoma.

Authors:  Insang Hwang; Seung Il Jung; Deok-Hyun Nam; Eu Chang Hwang; Taek Won Kang; Dong Deuk Kwon; Soo Bang Ryu
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

8.  Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma.

Authors:  Claudio B Murta; Alberto A Antunes; Marcos F Dall'Oglio; Alcides Mosconi; Kátia R Leite; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

9.  Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter.

Authors:  Shilajit D Kundu; Scott E Eggener
Journal:  Adv Urol       Date:  2009-01-26

10.  Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy.

Authors:  Kang Su Cho; Hyun Min Choi; Kyochul Koo; Sung Jin Park; Koon Ho Rha; Young Deuk Choi; Byung Ha Chung; Nam Hoon Cho; Seung Choul Yang; Sung Joon Hong
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.